colorectal cancer

Celyad gets the go-ahead to resume CAR-T trial for colorectal cancer as FDA lifts hold
Endpoints
Mon, 08/1/22 - 11:54 pm
Celyad
CAR-T
colorectal cancer
FDA
clinical trials
Merck to stop Phase 3 trial of Lynparza drug in colorectal cancer for futility
Seeking Alpha
Tue, 07/19/22 - 10:18 am
Merck
clinical trials
Lynparza
colorectal cancer
Seagen's potential breast cancer blockbuster Tukysa shows promise in colorectal cancer
Fierce Pharma
Mon, 05/23/22 - 06:46 pm
Seagen
Tukysa
breast cancer
colorectal cancer
clinical trials
Freenome aims to take on the big beasts
EP Vantage
Wed, 04/13/22 - 10:36 am
Freenome
liquid biopsies
colorectal cancer
diagnostics
Medtech
Guardant Health
Erasca, Eli Lilly partner for colorectal cancer therapy trial
Pharmaceutical Business Review
Fri, 03/11/22 - 10:37 am
Erasca
Eli Lilly
clinical trials
ERAS-007
colorectal cancer
Deaths in Keytruda combo study spur Celyad to pause trial of off-the-shelf CAR-T cell therapy
Fierce Biotech
Mon, 02/28/22 - 11:24 am
Celyad Oncology
CAR-T
clinical trials
Keytruda
CYAD-101
colorectal cancer
Liquid biopsy developers take aim at colorectal cancer
EP Vantage
Fri, 02/11/22 - 10:09 am
liquid biopsies
Medtech
diagnostics
colorectal cancer
EXACT Sciences
Guardant Health
Natera
Freenome gets $290M from Roche as it preps blood-based cancer test’s next steps
MedCity News
Wed, 01/12/22 - 10:59 am
Freenome
Roche
diagnostics
colorectal cancer
Servier Phase III colorectal cancer trial fails to meet primary endpoint
Pharmafile
Sun, 10/24/21 - 10:36 pm
Servier
colorectal cancer
clinical trials
Lonsurf
ESMO: Mirati pulls away from Amgen in colorectal cancer with rival KRAS drug
Fierce Biotech
Mon, 09/20/21 - 12:00 am
ESMO
Mirati Therapeutics
Amgen
colorectal cancer
Cardiff reveals early data on challenger to Amgen's KRAS crown
Fierce Biotech
Thu, 09/9/21 - 11:20 pm
Cardifff Oncology
Amgen
Onvansertib
colorectal cancer
ASCO 2021 – Guardant shoots for the moon
EP Vantage
Thu, 05/20/21 - 11:12 pm
ASCO 2021
Guardant Health
liquid biopsy
colorectal cancer
Colorectal Cancer Screening Should Start At Age 45, Experts Recommend
NPR
Tue, 05/18/21 - 11:25 pm
diagnostics
colorectal cancer
Exact Sciences-Guardant rivalry in colorectal testing market heats up
Medtech Dive
Wed, 02/17/21 - 11:23 pm
EXACT Sciences
Guardant Health
diagnostics
colorectal cancer
Ashion Analytics
M&A
Colorectal drug candidates focal point of new collaboration between Servier, Celsius Therapeutics
Endpoints
Mon, 12/21/20 - 10:56 am
Servier
Celsius Therapeutics
colorectal cancer
drug discovery
Merck gets positive CHMP opinion for Keytruda as first-line treatment for dMMR colorectal cancer
Pharmaceutical Business Review
Mon, 12/14/20 - 11:03 am
Merck
CHMP
Keytruda
colorectal cancer
Colorectal cancer screening should start five years earlier — at 45 — expert panel says
Stat
Wed, 10/28/20 - 10:44 am
colorectal cancer
diagnostics
ESMO: Where will Merck, Eisai take Keytruda-Lenvima next? Ovarian and colorectal cancer could be good options, data show
Fierce Pharma
Sun, 09/20/20 - 07:44 pm
Merck
Eisai
Keytruda
Lenvima
ovarian cancer
colorectal cancer
Merck & Co’s Keytruda gets new colorectal cancer use after month-long FDA review
Pharmaforum
Tue, 06/30/20 - 10:53 am
Merck
Keytruda
FDA
colorectal cancer
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Sat, 05/30/20 - 08:04 pm
Daiichi Sankyo
AstraZeneca
Enhertu
stomach cancer
colorectal cancer
lung cancer
ASCO 2020

Pages